Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design

This study will compare the incidence of major adverse cardiovascular events (MACEs) with androgen deprivation therapy (ADT) among men with advanced prostate cancer who are being treated with a gonadotropin-releasing hormone (GnRH) antagonist versus a GnRH agonist. Treatment of advanced prostate can...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JACC CardioOncology 2020-03, Vol.2 (1), p.70-81
Hauptverfasser:	Melloni, Chiara, Slovin, Susan F, Blemings, Allan, Goodman, Shaun G, Evans, Christopher P, Nilsson, Jan, Bhatt, Deepak L, Zubovskiy, Konstantin, Olesen, Tine K, Dugi, Klaus, Clarke, Noel W, Higano, Celestia S, Roe, Matthew T
Format:	Artikel
Sprache:	eng
Schlagworte:	Original Research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!